4.5 Review

Updates in Functional Movement Disorders: from Pathophysiology to Treatment Advances

Journal

CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS
Volume 22, Issue 5, Pages 305-311

Publisher

SPRINGER
DOI: 10.1007/s11910-022-01192-9

Keywords

Functional movement disorders; Functional neurological disorders; Psychogenic; Conversion; Neuropsychiatry; Neuroimaging

Ask authors/readers for more resources

This review discusses the latest advances in functional movement disorders, including risk factors, diagnosis, pathophysiology, neuroimaging studies, and treatment. There has been an increased interest in studying functional movement disorders in recent years, and international collaborative efforts have made progress in diagnosing and treating the disease. Neuroimaging studies have revealed functional and structural changes in motor and emotional brain circuits associated with functional movement disorders. Virtual therapy has also been widely used during the COVID-19 pandemic.
Purpose of Review This review discusses advances in functional movement disorders (FMD) over the past 3 years, with a focus on risk factors, diagnosis, pathophysiology, neuroimaging studies, and treatment. Recent Findings The past decade has brought a revived interest in functional movement disorders, with a growing number of studies exploring pathophysiological mechanisms. Here, we review recent studies demonstrating changes in attention, emotional and sensorimotor function in FMD. Through international collaborative efforts, progress has been made in defining biomarkers and outcome measures, an important prerequisite towards standardization of diagnosis and reporting of outcomes in clinical trials. Of particular interest are neuroimaging studies demonstrating functional and structural changes in motor and emotional brain circuits, deepening our understanding of FMD as a neurocircuit disorder and potentially paving the way towards new treatments. Currently available treatment modalities have shown successful outcomes via outpatient, inpatient, and virtual delivery. The last 3 years have seen tremendous efforts to better understand, diagnose, and treat FMD. The disease model has been broadened to include a biopsychosocial formulation, and insights on the pathophysiology on FMD are informing treatment efforts. Several international multidisciplinary research collaborations are underway to define biomarkers and best outcome measures, highlighting the path towards improved standardization of future treatment trials. Additionally, the rise of telemedicine during the COVID-19 pandemic has reduced geographic barriers and paved the way for virtual therapy sessions and self-guided programs.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available